Grading uterine endometrioid carcinoma a proposal that binary is best

American Journal of Surgical Pathology

Volumn 38, Issue 12, 2014, Pages 1583-1587

  Conlon, Niamh ^a   Leitao, Mario M ^a,b   Abu Rustum, Nadeem R ^a,b   Soslow, Robert A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; PATHOLOGY; PROCEDURES;

CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM GRADING;

EID: 84914674808     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000327     Document Type: Article

References (30)

1. Benda JA, Zaino R. Gynecologic Oncology Group Pathology Manual. Philadelphia, PA: Gynecologic Oncology Group; 1994.
2. FIGO Stages - 1988 Revision (announcement). Gynecol Oncol. 1989;35:125-127.
3. Surveillance, Epidemiology, and End Results (SEER) program. SEER Stat Fact Sheets: Endometrial Cancer. Available at: http://seer.cancer.gov/statfacts/html/corp.html. Accessed July 3, 2014.
4. Alkushi A, Abdul-Rahman Z, Lim P, et al. Description of a novel system for grading endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol. 2005;29:295-304.
5. Barlin JN, Zhou Q, St. Clair CM, et al. Classification and regression tree (CART) analysis of endometrial carcinoma: seeing the forest for the trees. Gynecol Oncol. 2013;130:452-456.
6. Zaino RJ. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol. 2009;28:1-9.
7. Scholten AN, Smit VT, Beerman H, et al. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer. 2004;100:764-772.
8. Lax SF, Kurman RJ, Pizer ES, et al. A Binary Architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol. 2000;24:1201-1208.
9. Sagae S, Saito T, Satoh M, et al. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading. Oncology. 2004;67:344-350.
10. Guan H, Semaan A, Bandyopadhyay S, et al. Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens. Int J Gynecol Cancer. 2011;21:654-660.
11. Gemer O, Uriev L, Voldarsky M, et al. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer. Eur J Surg Oncol. 2009;35:247-251.
12. Creutzberg CL, Van Putten WLJ, Koper PCM, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with Stage 1 endometrial carcinoma: multicentre randomized trial. Lancet. 2000;355:1404-1411.
13. Barlin JN, Soslow RA, Lutz M, et al. Redefining Stage I endometrial cancer incorporating histology, a binary grading system, myometrial invasion and lymph node assessment. Int J Gyn Cancer. 2013;23:1620-1628.
14. Leitao MM, Kehoe S, Barakat RR, et al. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol. 2008;111:244-248.
15. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer. 1987;60:2035-2041.
16. Al Hilli M, Podratz K, Dowdy S, et al. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol. 2013;131:103-108.
17. Bendifallah S, Genin AS, Naoura I, et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol. 2012;207:e1-e8.
18. Kumar S, Medeiros F, Dowdy S, et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012;127:525-531.
19. Mariani A, Dowdy SC, Keeney GL, et al. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol. 2004;95:120-126.
20. Zaino RJ, Kurman RJ, Diana KL, et al. The utility of the revised International Federation of Gynecology and Oncology histologic grading of endometrial endometrioid carcinoma using a defined nuclear grading system. Cancer. 1995;75:81-86.
21. Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumors of Female Reproductive Organs. Lyon: IARC; 2014.
22. Nielsen AL, Henrik KT, Nyholm HCJ. Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Oncology (FIGO) grading system of endometrial cancers with special emphasis on nuclear grading. Cancer. 1991;68:2303-2309.
23. Gilks CB, Oliva E, Soslow RA. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol. 2013;37:874-881.
24. Fadare O, Parkash V, Dupont WD, et al. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features. Am J Surg Pathol. 2012;36:1107-1118.
25. Hoang LN, McConechy MK, Kobel M, et al. Histotype-genotype correlation in 36 high-grade endometrial carcinomas. Am J Surg Pathol. 2013;37:1421-1432.
26. Han G, Sidhu D, Duggan MA, et al. Reproducibility of histological cell type in high-grade endometrial carcinoma. Mod Pathol. 2013;26:1595-1604.
27. Garg K, Soslow RA. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium. Adv Anat Pathol. 2012;19:1-10.
28. Soslow RA. High-grade endometrial carcinomas - strategies for typing. Histopathology. 2013;62:89-110.
29. Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67-73.
30. McConechy MK, Ding J, Cheang MCU, et al. Use of mutation profiles to refine the classification of endometrial carcinoma. J Pathol. 2012;228:20-30.